The Russian mercenary group has been accused of plundering Sudan’s gold resources to bankroll operations in Ukraine.
In late August it noted a disproportionately high number of reports of liver and kidney problems in patients receiving remdesivir compared with patients receiving other drugs for COVID-19. The European Medicines Agency (EMA) also announced this month that its safety committee had started a review to assess reports of acute kidney injuries in some patients taking remdesivir.
https://www.science.org/content/article/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug